Anika Therapeutics, Inc. (ANIK) Tops Q2 EPS by 3c, Revenue Light
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.85 -0.86%
EPS Growth %: -125.0%
Financial Fact:
Total revenue: 25.79M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -125.0%
Financial Fact:
Total revenue: 25.79M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
- Jana Partners urges Cooper Companies to replace CEO and explore asset sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
